In-House Versus Send-out Next Generation Sequencing Testing for Metastatic Non-Small Cell Lung Cancer Patients. a Budget Impact Analysis

Silas U, Blüher M, Dumanois R, Saunders R

presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Boston, USA